Loading…
Support or opposition to letting the government negotiate lower prescription drug prices with drug companies, in CES 2020 and 2022.
AI-matched An AI model grouped these questions and mapped their answers onto shared categories, and a second AI review checked and corrected the grouping and mapping. No person has checked it: compare the question wordings and the answer mapping below before reading the lines against each other.
Latest: 86% answered “Support” in CES: Government negotiation of prescription drug prices, 2022.
Shares of everyone asked, including non-answers. Each point is one survey wave at the middle of its field period. Lines from different surveys are never spliced together.
| Line | Question | Match | How answers map |
|---|---|---|---|
| CES: Government negotiation of prescription drug prices | Government negotiation of prescription drug prices Thinking now about health care policy, would you support or oppose each of the following proposals? [Allow the government to negotiate with drug companies to get a lower price on prescription drugs that would apply to both Medicare and private insurance. Maximum negotiated price could not exceed 120% of the average prices in 6 other countries.] Caveat: Reference question; the wording shown is truncated, but the scale is binary support/oppose. | identical | Support → Support; Oppose → Oppose |
| CES: Government negotiation of prescription drug prices | Government negotiation of prescription drug prices Thinking now about health care policy, would you support or oppose each of the following proposals? [Allow the government to negotiate with drug companies to get a lower price on prescription drugs that would apply to both Medicare and private insurance. Maximum negotiated price could not exceed 120% of the average prices in 6 other countri] Caveat: 2022 wording adds detail: the price applies to Medicare and private insurance, with a cap at 120% of the average price in 6 other countries. | equivalent | Support → Support; Oppose → Oppose |